In public health, the generation, management, and transfer of knowledge all need major improvement. Problems in generating knowledge include an imbalance in research funding, publication bias, unnecessary studies, adherence to fashion, and undue interest in novel and immediate issues.
Impaired generation of knowledge, combined with a dated and inadequate process for managing knowledge and an inefficient system for transferring knowledge, mean a distorted body of evidence available for decisionmaking in public health. This article hopes to stimulate discussion by proposing a Global Registry of Anticipated Public Health Studies.
This prospective, comprehensive system for tracking research in public health could help enhance collaboration and improve efficiency. Practical problems must be discussed before such a vision can be further devel- Editors announced that, from July 2005, researchers submitting articles to 11 medical journals would be asked to report the full results of clinical trials, both positive and negative, and that the journals would not publish studies unless they had been included in a public registry at their inception. 1 This policy should guard against selective reporting of trials and the distortion of the body of evidence available for clinical decisionmaking. 2 The International Committee of Medical Journal Editors has now specified the minimum registration data set. 3, 4 We believe that similar considerations and standards are needed for nontrial public health studies. Public health studies are studies related to the efforts organized by society to protect, promote, and restore the people's health, 5 many of which are observational and nonexperimental, or involve "natural experiments." 6 We examined the current problems in generating, managing, and transferring knowledge in public health and have described a vision for a future Global Registry of Anticipated Public Health Studies (GRAPHS). Knowledge generation and use are a critical foundation of effective public health programs and policies, but many problems are evident in current practice. Because this article covers a broad scope, it can discuss neither all of the issues nor each issue in sufficient depth. Also, the proposed vision is not meant to address all of the numerous practical issues but to generate public discussion. We are describing a vision to encourage possible solutions to important problems; we are not making a concrete proposal. For the purpose of this article, the knowledge cycle is divided into 3 stages: (1) knowledge generation (also known as knowledge acquisition or creation) 7 ; (2) knowledge management (exploitation and development of the knowledge assets) 8 ; and (3) knowledge transfer (also known as knowledge exchange, dissemination, access, brokering, or translation). 7 
THE NEED Knowledge Generation
The first problem in generating knowledge is the imbalance in the funding of health care versus health protection, which is mirrored in the funding of medical versus public health research. For example, in the United States, less than 1% of the US $1.9 trillion annually spent on health care is spent on health protection and prevention. 9 In the United Kingdom, although there is a government commitment to improving population health and prevention, 10 only 2% of cancer research funding 11 and 0.4% of public health research 12 are provided for prevention. The problem is exacerbated because few major journals are interested in publishing public health research. 6 Thus, the Guide to Community Preventive Services, 13 a major US effort to synthesize current evidence supporting health promotion and prevention programs, reveals significant gaps (lack of studies of reasonable quality) in the current knowledge base when reviewing evidence to support health promotion programs.
14 Furthermore, these knowledge gaps are not random and are found to be greater for interventions developed by the public sector versus those funded by private interests, for interventions that are more complex, longer term, and focused on upstream versus downstream causes of ill health, and in the developing versus the developed world. 15 The second problem is the accumulation of false-positive information, or the "false-positive research cycle." 16 The fourth problem is the funding of areas that are in fashion at the expense of others less in vogue but more important. Once a certain volume of research has been conducted in an area, a group of experts is formed whose vested interest in the topic influences future decisions on funding and publication.
The fifth problem is nonpublication of unpopular or even politically incorrect studies, or "culde-sac epidemiology." 19 Findings are shunned by the medical community and the media because they are deemed inappropriate (e.g., modern obstetric anesthesia as a possible risk factor for autism). The original studies are not replicated, even by the original investigators, and they are rarely quoted after publication. 19 The sixth problem relates to a novelty effect in research. Scientific journals, researchers, the media, and the public show a particular interest in "new" risk factors. Even very shaky evidence of possible new risk factors draws media and public attention that helps cast doubt on the known risk factors. Thus, researchers still go about searching for new risk factors for coronary heart disease after most are already known, as traditional risk factors for coronary heart disease have been found to explain 75% 20 to 90% 21 of new cases.
The seventh problem is the preoccupation of health researchers and practitioners with immediate but not necessarily the most important health issues. 22 Thus, to accentuate the first problem, the search for effective treatment often overshadows prevention, even though approximately half of all deaths in the United States in 2000 were driven by behavioral and social risk factors, with 40% attributable to tobacco, poor diet and physical inactivity, or excessive drinking of alcoholic beverages, all of them potentially preventable. 23 The eighth problem involves sacrificing external validity for internal validity. The problem arises when control measures used to ensure greater internal validity create artificial and unnatural circumstances that limit external validity (generalizability). Thus, an efficacious intervention in a controlled environment fails to work when used in normal practice circumstances. 24 Furthermore, many epidemiological biases affect the design, data collection, and analysis of public health research. 25, 26 At least 48 types of questionnaire biases have been identified. 27 Other issues with public health research include the underfunding of upstream research addressing disease prevention, the quality of research, and the importance of research synthesis. Added to this list are translation of research into practice, costeffectiveness analysis, and issues of falsenegatives and multiple end points within a single study (data on many of which may not be published).
Knowledge Management
The current process for managing knowledge produces a dated, incomplete evidence base for decisions. First, it usually takes many years from conceptualization of a public health research idea to publication of findings in the scientific literature. Systems for managing knowledge may also lack the staffing or other resources needed to maintain currency.
Second, search of the "gray" literature (e.g., unpublished and internal reports, technical documents), although improved by the Internet, remains notoriously difficult to conduct and replicate. 28 Even when a search uncovers relevant work, obtaining a copy can be difficult. In addition, some studies may never be written up, because time or interest is lacking. In the case of government agency-or industryfunded research, clearance and official checks may limit what can be released as public information. These problems are not resolved by even the most comprehensive literature search and review strategies, and they are accentuated among researchers who are not native English speakers or who reside in countries with less-developed access to the literature.
Knowledge Transfer
The current process for transferring public health knowledge is hindered by the insufficient investment in directed research. In the end, the clear identification of priorities by decisionmakers and funders of research may mean relatively little. Research may be funded and conducted in a targeted area, but the findings produced do not necessarily answer the strategic questions that guide policy and practice. The result is that those who make decisions in public health are often frustrated by their inability to base those decisions on relevant research. 29 Much of public health research focuses on the discovery and characterization of health problems, rather than on the effective interventions or possible solutions. Yet, policymakers are often looking for intervention studies. Community-based intervention studies are less easily located, not only because they are methodologically challenging and, therefore, more difficult to conduct and publish, but many policy and program evaluations may be commissioned by nonacademic sponsors and, therefore, may not be published or easily accessible because they have less incentive to publish. 30 Even if community-based intervention studies are commissioned and published, there is still the challenge of how to apply the findings to the right population groups or community circumstances. There is a need for guidance for practitioners and decisionmakers on how best to assess external validity of studies and to apply the evidence in situ.
THE VISION
Our vision for a future knowledge-based information system is GRAPHS. Public health researchers and practitioners will benefit from such a globally collaborative registry, of which the key aim is to provide a platform for the following: (1) ensuring all of the relevant research data becomes publicly available, (2) the identification of research and researchers on specific topics, (3) the cross-validation of studies, (4) the prioritization of research funding for issues of national and international interest, (5) the advancement of research to the next level, and (6) the identification of knowledge gaps.
Research studies on human health, ecological and social studies (including economic evaluation and policy analysis), and other public health investigations would be entered in GRAPHS when they are commissioned or when they are funded by a granting agency. Research findings, whether positive or negative, will be tracked. The method of tracking would be similar to that used by the Cochrane Collaboration 31 and Campbell Collaboration, 32 global registries for evidence on controlled-trial interventions in health care and the social, behavioral, and educational arenas, respectively. To keep up to date, the registry will need an automated reminder system for researchers to submit ongoing project updates. 33 A unique registration number and standardized format will also be needed. Results will be classified by study design 34 and the type of data
analysis. An effective search engine will be needed to retrieve information. 35 GRAPHS must be freely accessible to all interested parties, which raises the issue of protecting intellectual rights. Operational guidelines should strike a careful balance between open access and the privacy (personal information, ownership of data, and copyright) of the individual researchers. More detailed information could be accessed by researchers with an access code.
Ideally, GRAPHS should include studies as soon as the research process begins and, thus, well before any results are obtained or published. GRAPHS registration could be required by all funding bodies and as a condition of granting ethical approval. It will be fundamentally different from a meta-analysis or any current system for synthesizing research, such as Cochrane or Campbell, 31, 32 which are inherently retrospective. GRAPHS needs not be built from scratch. For example, it could be based on a process similar to that of US institutional review boards or other granting agencies that require researchers to obtain approval for their studies. To satisfy the institutional review board process, researchers must present comprehensive study protocols. Second, it could link to existing clinical trials databases and current efforts to catalog new knowledge. Examples include the US federal databases 36 46 ; and the Sharing Point Server database, which has a heavy emphasis on developing countries. 47 Fourth, "hierarchies of evidence" tables, indicating appropriate research designs to answer specific types of questions and their application frameworks, are available to guide the rating and use of evidence from research studies. 34 Fifth, the science of "bibliometrics" (statistical bibliography) 48 can help describe and analyze "information epidemics," for example, by studying the numbers of papers published on a new idea and charting their spread. 49 Sixth, efforts in the se- These include meta-analysis 54 ; systematic reviews of qualitative studies 55, 56 ; translation of research into practice, such as the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework 57, 58 ; and reporting standards and rating scales using Consolidated Standards of Reporting Trials criteria. 59 GRAPHS needs to resolve issues such as how criteria for methodologic quality in reporting (Consolidated Standards of Reporting Trials) could be applied to observational research. Progress has been made. For example, Reach, Effectiveness, Adoption, Implementation, and Maintenance has been used to structure a set of criteria for judging the external validity, generalizability, and relevance of a research study beyond the setting and circumstances in which it was conducted and in line with Consolidated Standards of Reporting Trials.
53
Because both internal and external validity are important for population health studies, a final component of GRAPHS could be the incorporation of Reach, Effectiveness, Adoption, Implementation, and Maintenance principles. 53 When studies are complete, authors could be asked to provide specification of the key components of an evidencebased program and the range of permissible adaptation that would still retain the essential elements of the original efficacy study. In this way, GRAPHS would help provide a platform for research transfer, with explicit  TOWARD A PREPARED FUTURE FOR PUBLIC HEALTH  consideration being given to reach representativeness, program implementation, outcomes of decisionmaking, maintenance, and institutionalization.
DISCUSSION
There is no quick fix to the current problems in generating, managing, and transferring knowledge in public health. A broad, well-conceived approach is needed, such as GRAPHS.
Strengths
GRAPHS would minimize the effect of the false-positive research cycle by including results of all studies or at least providing a clear paper trail of all studies initiated. It could complement research synthesis efforts by making it easier to identify all of the applicable studies. It would provide a more comprehensive evidence base to facilitate decisionmaking; for example, one would have a better idea of the proportion of studies with positive results. In the future, simple counts of positive and negative studies will be replaced by more sophisticated techniques to adjust for study quality and to properly assess causation.
In addition, GRAPHS would help researchers and granting agencies avoid excessive investment in topics that are being overly studied (circular epidemiology) and allow due consideration of the legitimate need to replicate some studies. This would allow better use of limited public health research funding. Furthermore, it would help identify gaps in our knowledge, which could lead to a focused call for more studies. 60 It would also provide added value to the knowledge base by systematically evaluating all studies, indicating, for example, whether a false-positive study is the result of random chance or poor design. Finally, it would strengthen opportunities for national and international collaboration among investigators.
Weaknesses and Unanswered Questions
GRAPHS would require much discussion among stakeholders to hammer out its details, such as who will fund it, provide it with data, and use its information. Some will question whether the investment (both initial and ongoing) would be warranted. In addition, the primary targets and audiences must be defined more sharply. One should also ask how GRAPHS information would be used by nonacademic audiences, such as policymakers, how it would facilitate knowledge transfer, how it would be integrated with other research registry systems, and whether it might inhibit new research.
It is important to address whether notification should be required by funders of research, whether there should be incentives and penalties to promote registration, or both. Although restrictions by editors on publishing nonregistered studies may be effective, failing to publish such studies may exacerbate the problem of publication bias, which the GRAPHS is designed to combat.
More generally, the question must be settled of how much detail of ongoing research should be put in the public domain and why it should be put there-to better society or simply to encourage collaboration? 
Threats and challenges
The most critical challenge to GRAPHS involves a relative lack of incentives for individual researchers to submit information on current or planned studies, let alone keep it updated. The experience of universities and other research institutions is instructive here because they often fail to get their own researchers, with their busy schedules, to even complete their institutional profiles of research and expertise on the Internet.
There is also the issue of intellectual property rights and the fear of having one's ideas stolen. Only on publication do investigators believe their intellectual property rights can be defended. This challenge is even more formidable in basic science, where commercial applications or patents may be at stake.
OPPORTUNITIES
We believe that, in the short term, the incentives for GRAPHS most probably lie with the funders of research in each country who could keep a better log of what they fund and then link these logs internationally. In addition, major users of research, such as governments, may wish to pay for registries of current or forthcoming evidence on key public policy issues. At least in government, many scientists and other researchers conduct studies according to perceived policy needs. Shared information, collaborative efforts, and wide consultation are encouraged during the whole research process. This culture may one day be extended to academic research. Systems for public health research may then be re-engineered to link more closely with policy and practice. GRAPHS should have, at minimum, the capacity to actively monitor research outcomes and perform basic knowledge transfer functions. It should document dissemination of research to date, including citation in policy documents. Because policymakers are not likely to read primary research papers or project proposals or even full structured reviews, 1-or 2-page policy briefs or lay summaries would be necessary. 29 In the future, granting agencies may become more assertive with journals, and in turn journals with researchers, in pushing the case that negative studies (of sufficient methodologic quality, including statistical power) are important to publish. In addition, GRAPHS may establish global standards to assist journals and granting agencies in prioritizing research for publication and funding, perhaps even addressing the issue of when the evidence for a finding is sufficient to obviate the need for future studies in that area. In return, scientific journals may establish guidelines that studies are to be published only if they had been initially registered with GRAPHS at inception.
With widespread computer and communication technology, GRAPHS may one day become a virtual database of all studies in public health, readily accessible to all researchers and decisionmakers in every country, subject to suitable anonymization and data safeguards. With good decision aids and access to either raw data or aggregated data, research users could evaluate the research objectively. This would be perceived by some as risky, but scrutiny can only improve an investigator's work.
CONCLUSIONS
GRAPHS, for all its potential value, would be a major challenge to implement. The need to allocate formidable resources and overcome sociopolitical considerations may keep such a global registry from being born. Conversely, progress in technology and informatics, as well as a rethinking of the research enterprise, may soon make implementation much easier to achieve. This article is a call for public discussion to improve the way new public health scientific knowledge is produced, managed, and transferred.
